Chinese Vice-Premier Ding Xuexiang has urged Hong Kong’s legislature to deliver more “practical outcomes” that align with the city’s actual conditions and meet Beijing’s expectations under the executive-led governance system. Emphasising the importance of the executive-led system for the second day in a row, the state leader reiterated on Saturday that its implementation was not solely the respons...
Chinese Vice-Premier Ding Xuexiang has urged Hong Kong’s legislature to deliver more “practical outcomes” that align with the city’s actual conditions and meet Beijing’s expectations under the executive-led governance system. Emphasising the importance of the executive-led system for the second day in a row, the state leader reiterated on Saturday that its implementation was not solely the responsibility of the city leader or the government, as he outlined his expectations for the Legislative Council. Ding, head of the Central Leading Group on Hong Kong and Macau Affairs, cited that President Xi Jinping had earlier set out new requirements for the city’s governance in response to the “new circumstances” and stressed that implementing the executive-led system was a shared responsibility of the legislature, judiciary and all sectors of society. Legco president Starry Lee has highlighted the legislature’s efforts to support the national 15th five-year plan. Photo: Eugene Lee “After this topic has been raised, all sectors must strengthen their research, exploration and practice, continuously summarising experiences,” Ding told the city’s deputies to the national legislature in a meeting during the “two sessions”. Advertisement “In particular, the Legco has tremendous scope to contribute under the executive-led system. There is vast room for practice, exploration and theoretical research. “I hope that, during the eighth Legco term, the legislature under the leadership of Starry Lee Wai-king will explore and study this topic well, and produce more practical outcomes that fit Hong Kong’s actual situation and meet the requirements of the central government.” Advertisement The sixth-ranked Politburo Standing Committee member made his remarks in response to a speech by Starry Lee, the Legco president and the city’s sole representative on the National People’s Congress (NPC) Standing Committee.
Broadcom (AVGO) reported its Q1 earnings on March 4. The company’s report was strong, with revenue hitting 29% year-over-year growth to a record $19.3 billion. The stock closed 4.8% higher at $322.77 on the next day, according to Yahoo Finance. AI-heavy stock not crashing following the earnings ...
Broadcom (AVGO) reported its Q1 earnings on March 4. The company’s report was strong, with revenue hitting 29% year-over-year growth to a record $19.3 billion. The stock closed 4.8% higher at $322.77 on the next day, according to Yahoo Finance. AI-heavy stock not crashing following the earnings ...
If you compare the latest quarterly results from Walmart (WMT +0.45%) and BJ's Wholesale Club (BJ 1.69%), one contrast is impossible to ignore. In its fiscal fourth quarter, Walmart's operating income jumped 10.8% year over year, easily outpacing its 5.6% revenue growth. BJ's, meanwhile, saw its total revenue increase by the exact same 5.6% in its most recent quarter, but its operating income actu...
If you compare the latest quarterly results from Walmart (WMT +0.45%) and BJ's Wholesale Club (BJ 1.69%), one contrast is impossible to ignore. In its fiscal fourth quarter, Walmart's operating income jumped 10.8% year over year, easily outpacing its 5.6% revenue growth. BJ's, meanwhile, saw its total revenue increase by the exact same 5.6% in its most recent quarter, but its operating income actually slipped 0.2% year over year. But BJ's does have an edge on its much larger competitor in one crucial area: valuation. So, which stock is the better buy today: the better operator with a demanding valuation, or the cheaper warehouse club? Walmart: a shifting profit profile Beneath Walmart's 5.6% top-line growth in fiscal Q4 were several underlying drivers pointing to a fundamentally improving business. The defining metric was the company's surging global e-commerce sales, which rose 24% year over year and now account for a record 23% of total net sales. Backing up this digital strength, U.S. comparable sales (excluding fuel) rose 4.6%, driven by a 2.6% increase in transactions. This proves Walmart is still driving real traffic, not just leaning on higher prices. Even more importantly, the company's highest-margin revenue streams are growing the fastest. Walmart's global advertising business surged 37% year over year in the quarter, with its U.S. ad segment, Walmart Connect, rising 41%. Further, global membership fee revenue increased 15.1%. All of these underlying factors help explain why the company commands such a high valuation. Its business is transforming. Expand NASDAQ : WMT Walmart Today's Change ( 0.45 %) $ 0.55 Current Price $ 123.86 Key Data Points Market Cap $983B Day's Range $ 121.62 - $ 124.18 52wk Range $ 79.81 - $ 134.69 Volume 1.3M Avg Vol 31M Gross Margin 25.40 % Dividend Yield 0.76 % And then there is Sam's Club. Walmart's warehouse club segment posted 4% comparable sales growth excluding fuel and 23% e-commerce growth in the quarter. And management no...
Regencell Bioscience (RGC 2.52%) has a surprisingly large market cap of nearly $12 billion. The stock is up a shocking 21,000% over the past year. It started the 52-week period as a penny stock. Investors need to tread with caution and not get lured in by the massive price gain. What does Regencell Bioscience do? Regencell describes itself as an early stage bioscience company. That basically means...
Regencell Bioscience (RGC 2.52%) has a surprisingly large market cap of nearly $12 billion. The stock is up a shocking 21,000% over the past year. It started the 52-week period as a penny stock. Investors need to tread with caution and not get lured in by the massive price gain. What does Regencell Bioscience do? Regencell describes itself as an early stage bioscience company. That basically means it's researching drugs it believes may have promise, but it hasn't found anything yet. This is a high-risk area of the pharmaceutical sector that only the most aggressive investors should consider. If a bioscience company's research leads to a marketable product, its stock could take off. If it doesn't, the company could have trouble remaining a going concern. It is a bit of a moonshot type of investment. In order to justify buying a company like Regencell, you need to believe very strongly in the drug candidates that the company is researching. Most investors should stick to more established pharmaceutical companies that already have a portfolio of patented drugs. Regencell has spent 14 years examining "TCM" What's interesting about Regencell is that it has been operating since 2014 and still doesn't have a patented drug. Its focus is on traditional Chinese medicine, which the company usually just describes as TCM on its website. Expand NASDAQ : RGC Regencell Bioscience Today's Change ( -2.52 %) $ -0.61 Current Price $ 23.60 Key Data Points Market Cap $12B Day's Range $ 23.60 - $ 24.82 52wk Range $ 0.10 - $ 83.60 Volume 1.9K Avg Vol 457K The foreign company's annual report states the risks very clearly, summing the problem up in one sentence: We have no saleable products and have not generated any revenue from product sales. Unless you are deeply versed in TCM and have a strong belief that Regencell is on the verge of some breakthrough, you should probably avoid this stock. Why I would avoid Regencell (and what I would buy instead) I wouldn't touch Regencell with a 10-foo...
Key Points Regencell Bioscience is an early-stage bioscience company that has been working since 2014 to develop a marketable drug. The company's focus area is traditional Chinese medicine. 10 stocks we like better than Regencell Bioscience › Regencell Bioscience (NASDAQ: RGC) has a surprisingly large market cap of nearly $12 billion. The stock is up a shocking 21,000% over the past year. It start...
Key Points Regencell Bioscience is an early-stage bioscience company that has been working since 2014 to develop a marketable drug. The company's focus area is traditional Chinese medicine. 10 stocks we like better than Regencell Bioscience › Regencell Bioscience (NASDAQ: RGC) has a surprisingly large market cap of nearly $12 billion. The stock is up a shocking 21,000% over the past year. It started the 52-week period as a penny stock. Investors need to tread with caution and not get lured in by the massive price gain. What does Regencell Bioscience do? Regencell describes itself as an early stage bioscience company. That basically means it's researching drugs it believes may have promise, but it hasn't found anything yet. This is a high-risk area of the pharmaceutical sector that only the most aggressive investors should consider. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » If a bioscience company's research leads to a marketable product, its stock could take off. If it doesn't, the company could have trouble remaining a going concern. It is a bit of a moonshot type of investment. In order to justify buying a company like Regencell, you need to believe very strongly in the drug candidates that the company is researching. Most investors should stick to more established pharmaceutical companies that already have a portfolio of patented drugs. Regencell has spent 14 years examining "TCM" What's interesting about Regencell is that it has been operating since 2014 and still doesn't have a patented drug. Its focus is on traditional Chinese medicine, which the company usually just describes as TCM on its website. The foreign company's annual report states the risks very clearly, summing the problem up in one sentence: We have no saleable products and have not generated any revenue from product sales...
Palantir Technologies Inc. CEO Alex Karp did not mince words at a recent industry summit. He told Silicon Valley that trying to gut white-collar employment while also cutting off the military is a fast track to having your technology seized by the government. The remarks were delivered at the a16z American Dynamism Summit. "If Silicon Valley believes we're going to take everyone's white collar job...
Palantir Technologies Inc. CEO Alex Karp did not mince words at a recent industry summit. He told Silicon Valley that trying to gut white-collar employment while also cutting off the military is a fast track to having your technology seized by the government. The remarks were delivered at the a16z American Dynamism Summit. "If Silicon Valley believes we're going to take everyone's white collar jobs AND screw the military…If you don't think that's going to lead to the nationalization of our technology— you're retarded." -Alex Karp @palantirtech at @a16z American Dynamism Summit pic.twitter.com/4tslXaDP6t Katherine Boyle, co-founder of American Dynamism and general partner at a16z, posted a video clip of Karp’s comments on X on Wednesday. Don't Miss: Karp’s Blunt Warning To The Tech Industry “If Silicon Valley believes we’re going to take everyone’s white collar jobs AND screw the military…If you don’t think that’s going to lead to the nationalization of our technology — you’re retarded,” Karp said. Palantir CTO Shyam Sankar has also pushed back on the doom-and-gloom narrative around AI and jobs. Speaking on the All-In podcast in July 2025, Sankar argued AI gives workers “superpowers” rather than pink slips. The comment lands at a charged moment. The AI industry is navigating mounting tension between its commercial ambitions, its workforce impact, and its complicated relationship with the U.S. defense establishment. Anthropic CEO Had Already Sounded The Alarm On Jobs Karp’s remarks follow a warning issued in January by Anthropic CEO Dario Amodei. In a roughly 20,000-word essay, Amodei argued that the risks AI poses are not being taken seriously — and that a labor market “shock” unlike anything seen before is coming. See Also: Disney Was Built on Character IP — This Pre-IPO Company Is Using the Same Playbook “New technologies often bring labor market shocks, and in the past, humans have always recovered from them, but I am concerned that this is because these previous ...
Palantir Technologies Inc. CEO Alex Karp did not mince words at a recent industry summit. He told Silicon Valley that trying to gut white-collar employment while also cutting off the military is a fast track to having your technology seized by the government. The remarks were delivered at the a16z American Dynamism Summit. "If Silicon Valley believes we're going to take everyone's white collar job...
Palantir Technologies Inc. CEO Alex Karp did not mince words at a recent industry summit. He told Silicon Valley that trying to gut white-collar employment while also cutting off the military is a fast track to having your technology seized by the government. The remarks were delivered at the a16z American Dynamism Summit. "If Silicon Valley believes we're going to take everyone's white collar jobs AND screw the military…If you don't think that's going to lead to the nationalization of our technology— you're retarded." -Alex Karp @palantirtech at @a16z American Dynamism Summit pic.twitter.com/4tslXaDP6t Katherine Boyle, co-founder of American Dynamism and general partner at a16z, posted a video clip of Karp’s comments on X on Wednesday. Don't Miss: Karp’s Blunt Warning To The Tech Industry “If Silicon Valley believes we’re going to take everyone’s white collar jobs AND screw the military…If you don’t think that’s going to lead to the nationalization of our technology — you’re retarded,” Karp said. Palantir CTO Shyam Sankar has also pushed back on the doom-and-gloom narrative around AI and jobs. Speaking on the All-In podcast in July 2025, Sankar argued AI gives workers “superpowers” rather than pink slips. The comment lands at a charged moment. The AI industry is navigating mounting tension between its commercial ambitions, its workforce impact, and its complicated relationship with the U.S. defense establishment. Anthropic CEO Had Already Sounded The Alarm On Jobs Karp’s remarks follow a warning issued in January by Anthropic CEO Dario Amodei. In a roughly 20,000-word essay, Amodei argued that the risks AI poses are not being taken seriously — and that a labor market “shock” unlike anything seen before is coming. See Also: Disney Was Built on Character IP — This Pre-IPO Company Is Using the Same Playbook “New technologies often bring labor market shocks, and in the past, humans have always recovered from them, but I am concerned that this is because these previous ...